Santhera Pharmaceuticals Holding AG (SW:SANN) — Stock Price
Santhera Pharmaceuticals Holding AG (SW:SANN) is currently trading at CHF16.40 CHF, up 3.54% today. Over the past 52 weeks, shares have ranged between CHF9.58 and CHF18.54. This page tracks Santhera Pharmaceuticals Holding AG's live share price on the SW exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of Santhera Pharmaceuticals Holding AG.
Santhera Pharmaceuticals Holding AG (SANN) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Santhera Pharmaceuticals Holding AG's daily closing share price and trading volume on the SW exchange over the past year, giving a clear view of recent price momentum and liquidity.
Santhera Pharmaceuticals Holding AG Income Statement — Revenue, Profit & Earnings by Year
Santhera Pharmaceuticals Holding AG's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | CHF77.19 Million | CHF39.12 Million | CHF103.41 Million | CHF7.47 Million | CHF-1.59 Million |
| Cost of Revenue | CHF62.72 Million | CHF15.53 Million | CHF3.23 Million | CHF3.59 Million | CHF3.77 Million |
| Gross Profit | CHF14.47 Million | CHF22.96 Million | CHF100.18 Million | CHF3.88 Million | CHF-5.36 Million |
| Research & Development | CHF22.22 Million | CHF26.47 Million | CHF18.67 Million | CHF30.54 Million | CHF29.71 Million |
| SG&A | CHF30.77 Million | CHF19.48 Million | CHF21.18 Million | CHF14.56 Million | CHF12.72 Million |
| Total Operating Expenses | CHF52.28 Million | CHF56.69 Million | CHF31.34 Million | CHF55.86 Million | CHF51.53 Million |
| Operating Income | CHF-37.82 Million | CHF-33.38 Million | CHF68.84 Million | CHF-51.98 Million | CHF-56.89 Million |
| EBITDA | CHF-32.13 Million | CHF-15.89 Million | CHF79.17 Million | CHF-46.78 Million | CHF-34.57 Million |
| EBIT | CHF-37.82 Million | CHF-21.53 Million | CHF76.13 Million | CHF-50.43 Million | CHF-38.29 Million |
| Interest Expense | CHF11.56 Million | CHF20.17 Million | CHF21.31 Million | CHF20.19 Million | CHF16.42 Million |
| Income Before Tax | CHF-49.05 Million | CHF-41.66 Million | CHF54.82 Million | CHF-70.62 Million | CHF-54.72 Million |
| Income Tax Expense | CHF185.00K | CHF312.00K | CHF38.00K | CHF460.00K | CHF809.00K |
| Net Income | CHF-49.24 Million | CHF-41.97 Million | CHF54.78 Million | CHF-71.08 Million | CHF-55.53 Million |
Santhera Pharmaceuticals Holding AG Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Santhera Pharmaceuticals Holding AG's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | CHF148.09 Million | CHF152.49 Million | CHF109.63 Million | CHF63.73 Million | CHF91.12 Million |
| Total Current Assets | CHF80.24 Million | CHF75.81 Million | CHF34.66 Million | CHF3.06 Million | CHF24.64 Million |
| Cash & Equivalents | — | CHF22.59 Million | CHF21.84 Million | — | CHF21.21 Million |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | CHF26.04 Million | CHF13.88 Million | CHF440.00K | CHF1.09 Million | CHF1.94 Million |
| Inventory | CHF24.87 Million | CHF17.53 Million | CHF1.81 Million | CHF108.00K | CHF428.00K |
| Property, Plant & Equipment | — | CHF2.57 Million | CHF582.00K | — | CHF1.32 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | CHF159.90 Million | CHF124.79 Million | CHF49.69 Million | CHF107.41 Million | CHF89.79 Million |
| Total Current Liabilities | CHF62.17 Million | CHF46.14 Million | CHF44.31 Million | CHF49.41 Million | CHF32.78 Million |
| Long-term Debt | CHF32.73 Million | CHF31.73 Million | CHF0.00 | CHF21.08 Million | CHF25.80 Million |
| Net Debt | CHF75.33 Million | CHF248.00K | CHF-7.34 Million | CHF43.08 Million | CHF21.77 Million |
| Total Stockholder Equity | CHF-11.82 Million | CHF27.70 Million | CHF59.94 Million | CHF-43.69 Million | CHF1.33 Million |
| Retained Earnings | CHF-663.93 Million | CHF-614.69 Million | CHF-572.72 Million | CHF-627.50 Million | CHF-556.42 Million |
Santhera Pharmaceuticals Holding AG Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Santhera Pharmaceuticals Holding AG generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | CHF-34.76 Million | CHF-35.53 Million | CHF47.27 Million | CHF-29.84 Million | CHF-37.36 Million |
| Capital Expenditures | CHF52.00K | CHF151.00K | CHF23.74 Million | CHF3.96 Million | CHF15.00K |
| Free Cash Flow | CHF-34.81 Million | CHF-35.68 Million | CHF23.53 Million | CHF-33.80 Million | CHF-37.37 Million |
| Investing Cash Flow | CHF-122.00K | CHF-61.00K | CHF-18.04 Million | CHF-3.93 Million | CHF69.00K |
| Financing Cash Flow | CHF16.38 Million | CHF46.08 Million | CHF-171.00K | CHF13.99 Million | CHF46.02 Million |
| Dividends Paid | — | — | — | — | CHF32.66 Million |
| Stock-Based Compensation | CHF4.25 Million | CHF3.97 Million | CHF5.99 Million | CHF5.45 Million | CHF2.76 Million |
| Depreciation | CHF5.69 Million | CHF5.65 Million | CHF3.04 Million | CHF9.86 Million | CHF3.72 Million |
| Change in Cash | CHF-18.48 Million | CHF10.55 Million | CHF29.02 Million | CHF-19.86 Million | CHF8.80 Million |
Santhera Pharmaceuticals Holding AG Earnings History — EPS Actual vs. Analyst Estimates
Track Santhera Pharmaceuticals Holding AG's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 27, 2026 | — | 0.16 | — |
| Dec 31, 2025 | — | 0.94 | — |
| Dec 10, 2025 | -0.37 | -0.26 | -42.31% |
| Sep 10, 2025 | -0.60 | -0.60 | +0.00% |
| Apr 29, 2025 | -2.34 | -0.83 | -181.93% |
| Dec 31, 2024 | — | -0.83 | — |
| Dec 11, 2024 | -0.90 | -0.90 | +0.00% |
| Sep 12, 2024 | -1.35 | -0.94 | -43.62% |